Extracorporeal Lithotripter

The new device generation in extracorporeal shock wave lithotripsy for a gentle stone therapy
With the lithogold380 MTS presents a new generation of devices for tissue-friendly and efficient treatment of renal stones and other urological indications. The lithotripter is most notably characterized by its large focus (20 x 101 mm) and low energy peaks (max. 36.9 MPa) which guarantees an especially effective and kidney- conserving therapy.

The large system focus leads to the destruction of the stone with only one treatment in > 95% of all patients and drastically reduces the follow-up treatment rate.

lithogold380 is particularly suitable for the stone treatment in obese patients. Above all, the limited maximum pressure of the system guarantees a tissue-conserving therapy reducing the requirement for anaesthesia to a minimum.

At a glance:
High treatment success rate > 95 % with a single treatment
Reduced requirement for anaesthesia
Dual imaging with X-ray and ultrasound
Especially suitable for stone therapy in obese patients
Deep penetration depth (165 mm) reduces the incidence of treating
patients in the prone position
Large focus zone (20 x 101 mm) & peak pressure of 36.9 MPa max. = kidney-conserving lithotripsy
Low side effects
Latest generation electrohydraulic spark gap lithotripter

Indications in urology:
Renal calculi
Ureteral calculi